Cargando…

Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah’s Witness patient

Detalles Bibliográficos
Autores principales:	Schlaweck, Sebastian, Brossart, Peter, Heine, Annkristin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720736/ https://www.ncbi.nlm.nih.gov/pubmed/33438048 http://dx.doi.org/10.1007/s00277-021-04403-4

Ejemplares similares

Elotuzumab spares dendritic cell integrity and functionality
por: Schlaweck, Sebastian, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura treated with vincristine in a Jehovah's witness
por: Walia, Sandeep S., et al.
Publicado: (2011)

The stance of Jehovah's Witnesses on the use blood and Hospital Liaison Committee
por: Lee, Jong Hyun, et al.
Publicado: (2011)

ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah’s Witness congregation
por: Jillella, Anand P., et al.
Publicado: (2019)

COMPLEX PANCREATIC RESSECTIONS WITH VASCULAR INVOLVEMENT IN JEHOVAH'S WITNESSES: HOW TO APPROACH?
por: FERNANDES, Eduardo de Souza Martins, et al.
Publicado: (2016)

The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells
por: Braun, Christiane, et al.
Publicado: (2021)

Anesthetic management for transfusion-free Rastelli's procedure in a pediatric Jehovah's Witness patient
por: Kang, Sun-Hye, et al.
Publicado: (2013)

Anesthetic management of Jehovah's Witness patients.
por: Kim, W. O.
Publicado: (1991)

Sphenopalatine Ganglion Block for Postdural Puncture Headache After Labour Epidural in a Jehovah’s Witness Patient
por: Hasoon, Jamal, et al.
Publicado: (2020)

The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapy.
por: Johnson, P. W., et al.
Publicado: (1991)

Surgery in Jehovah's Witnesses – our experience
por: Trzciński, Radzisław, et al.
Publicado: (2015)

Evans Syndrome in a Jehovah’s Witness
por: Leonhardt, Lex P, et al.
Publicado: (2021)

Managing acute promyelocytic leukemia in patients belonging to the Jehovah’s Witness congregation
por: Jillella, Anand P., et al.
Publicado: (2017)

Poll - Jehovah's Witness Patient Among Baixada Santista and ABC Paulista Cardiologists
por: Mendes, Antonio, et al.
Publicado: (2013)

Targeting MEK in vemurafenib-resistant hairy cell leukemia
por: Caeser, Rebecca, et al.
Publicado: (2018)

A clinical challenge: Treatment of acute myeloid leukemia in a Jehovah's Witness
por: Cárdenas-Araujo, Daniela, et al.
Publicado: (2016)

Low‐dose vemurafenib in hairy cell leukemia patients with active infection
por: Bohn, Jan‐Paul, et al.
Publicado: (2019)

Successful transfusion-free pancreatectomy in Jehovah's Witness patients
por: Lee, Jong Oh, et al.
Publicado: (2016)

Blood Transfusion in Children: The Refusal of Jehovah’s Witness Parents’
por: Conti, Adelaide, et al.
Publicado: (2018)

52-Year-Old Jehovah’s Witness Female with Weakness
por: Weiner, Lindsay A., et al.
Publicado: (2018)

Liver transplantation in Jehovah's Witnesses: two cases report
por: Jeong, Ju-Young, et al.
Publicado: (2017)

Ceftriaxone-Induced Hemolytic Anemia in a Jehovah’s Witness
por: Tasch, James, et al.
Publicado: (2017)

Jehovah’s Witnesses and Their Compliance with Regulations on Smoking and Blood Treatment
por: Pavlikova, Barbara, et al.
Publicado: (2021)

Grieving the Living: The Social Death of Former Jehovah’s Witnesses
por: Ransom, Heather J., et al.
Publicado: (2021)

Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox
por: Robak, Tadeusz, et al.
Publicado: (2021)

Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients
por: Beck, Alyssa, et al.
Publicado: (2020)

Treatment of Jehovah’s witness patients. Surgical and medico-legal considerations
por: Terranova, C, et al.
Publicado: (2011)

First Lung Transplantation in Jehovah’s Witness Patient in Latin America
por: Fernandez-Trujillo, Liliana, et al.
Publicado: (2020)

Review of abdominal solid organ transplantation in Jehovah’s Witness patients
por: Figueiredo, Rodrigo S, et al.
Publicado: (2019)

Outcomes of cardiac surgery in Jehovah’s Witness patients: A review
por: Chambault, Aimee-Louise, et al.
Publicado: (2020)

The treatment of acute lymphoblastic leukemia in Jehovah's Witnesses and patients who cannot accept blood products
por: Nguyen, Nina, et al.
Publicado: (2022)

An Unusual Presentation of Hairy Cell Leukemia
por: Gajendra, Smeeta, et al.
Publicado: (2019)

Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia
por: Kauffman, Jeremy D., et al.
Publicado: (2017)

Pulmonary Valve Replacement in an Adult Jehovah's Witness with Tetralogy of Fallot
por: Ahmed, Talha, et al.
Publicado: (2020)

Surgical Experience of Posterior Fossa Meningioma in a Jehovah's Witnesses Patient
por: Eom, Ki Seong
Publicado: (2021)

Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report
por: Koerber, Ruth-Miriam, et al.
Publicado: (2021)

Induction with azacytidine followed by allogeneic hematopoietic stem cell transplantation in a Jehovah's Witness with acute monocytic leukemia
por: Garelius, Hege, et al.
Publicado: (2015)

Major Surgery in A Jehovah Witness with Sickle Cell Disease: Case Presentation
por: Anyaehie, Udo Ego, et al.
Publicado: (2016)

Surgical management in treatment of Jehovah's witness in trauma surgery in Indian subcontinent
por: Nishant,, et al.
Publicado: (2014)

Responses of advanced directives by Jehovah’s Witnesses on a gynecologic oncology service
por: Nagarsheth, Nimesh P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jcrrsplocdhd1napcam55nqois